Novo Nordisk A/S
| Date: | 16.6.2026 |
|---|---|
| Country: | Denmark |
| Customer: | Novo Nordisk A/S |
| Amount in DKK: | DKK 3,700 million |
| Amount in EUR: | EUR 500 million |
| Maturity: | 10 years |
| Business sector: | Connectivity & Consumer |
Project
The loan has been provided to finance pharmaceutical research and development (R&D) expenditures.
Fulfilment of NIB's mandate
The project contributes to productivity by supporting innovation and long‑term value creation in the pharmaceutical sector. The activities also contribute to maintaining Denmark’s position as a global life sciences hub.
Sustainability summary
The project is in line with the Bank’s sustainability policy and guidelines. No significant sustainability concerns have been identified.